生物制药专业特色是生物制药已成为国际和国内增长最快的行业之一，21世纪是生物技术的世纪，生物制药已成为侦破中国高新技术发展的重点。在全球金融危机的阴影下，新兴国家医药市场却表现得风光独好，中国的生物制药市场也分外亮丽。康科已于近年进入生物制药领域，不断延伸高端价值，持续投资开发新型生物药物制剂，目前自主品牌恩替卡韦片剂（最新治疗乙肝病毒药物）原料药及成品已经研制完成。该项目前景稳定，成本优势明显，市场需求巨大，预计在带来良好社会效益的同时，也将有较高的投资回报。
　　Biopharmaceutical specialty is that biopharmaceutical has become one of the fastest growing industries in the world and at home. The 21st century is the century of biotechnology, and biopharmaceutical has become the focus of China's high-tech development. In the shadow of the global financial crisis, the pharmaceutical market of emerging countries has performed well, and China's biopharmaceutical market is also particularly bright. Kangke has entered the field of biopharmaceuticals in recent years, continuously extending its high-end value, and continuously investing in the development of new biopharmaceutical preparations. At present, the raw material and finished products of entecavir tablets (the latest drug for hepatitis B virus) have been developed. The prospect of the project is stable, the cost advantage is obvious, and the market demand is huge. It is expected that the project will bring good social benefits and high return on investment.